文献速递膀胱癌与上尿路尿路上皮癌

全球膀胱癌发病与死亡趋势及其与吸烟和人均GDP的关联

Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.
PubMed 文献 · Eur Urol · 2020-09-21

该研究利用GLOBOCAN、五大洲癌症发病率及WHO死亡率数据库,分析2018年膀胱癌发病与死亡的性别年龄标化率及其与吸烟率、人均GDP的相关性,并评估10年趋势。结果显示吸烟与男性发病和死亡、女性发病显著相关,欧洲发病升而死亡降,亚洲发病降但男性死亡升。

要点

  • 吸烟率与男性膀胱癌发病(r=0.20)和死亡(r=0.38)正相关。
  • 吸烟率与女性膀胱癌发病(r=0.67)和死亡(r=0.22)正相关。
  • 人均GDP与男性(r=0.48)和女性(r=0.44)膀胱癌发病正相关。

核心结论

  • 全球膀胱癌发病与死亡呈现可观察的趋势变化。
  • 吸烟与膀胱癌发病和死亡显著相关。
  • 在吸烟率下降的国家,进一步降低膀胱癌死亡可能需要一定的经济能力。

研究设计与样本

  • 基于GLOBOCAN、五大洲癌症发病率(CI5)和WHO死亡率数据库的全球分析。
  • 吸烟率数据来自WHO全球卫生观察站,人均GDP来自联合国人类发展报告。
  • 分析包括2018年横断面关联分析及10年时间趋势的joinpoint回归分析。

主要发现

  • 男性吸烟率与膀胱癌发病(r=0.20)和死亡(r=0.38)正相关。
  • 女性吸烟率与膀胱癌发病(r=0.67)和死亡(r=0.22)正相关。
  • 人均GDP与男性(r=0.48)和女性(r=0.44)膀胱癌发病正相关;与男性死亡弱正相关(r=0.19),与女性死亡无相关(r=0.06)。
  • 多因素线性回归显示吸烟与男性膀胱癌发病和死亡、女性膀胱癌发病显著相关。
  • 欧洲膀胱癌发病增加但死亡下降,亚洲发病下降但男性死亡增加。

关键数值与推荐

  • 2018年全球膀胱癌新发病例约550 000例。
  • 男性吸烟率与膀胱癌发病的相关系数r=0.20,与死亡的相关系数r=0.38。
  • 女性吸烟率与膀胱癌发病的相关系数r=0.67,与死亡的相关系数r=0.22。
  • 人均GDP与男性膀胱癌发病的相关系数r=0.48,与女性发病的相关系数r=0.44。

临床怎么用

  • 临床及公共卫生层面应重视吸烟对膀胱癌发病和死亡的影响。
  • 在吸烟率下降的国家,需关注经济水平对进一步降低膀胱癌死亡的作用。

局限性

  • 欠发达国家可能存在癌症发病漏检和漏报。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bladder cancer is a major urological disease, with approximately 550 000 new cases diagnosed in 2018. OBJECTIVE: We examined gender-specific incidence and mortality patterns, and trends of bladder cancer from a global perspective. We further investigated their associations with tobacco use and gross domestic product (GDP) per capita. DESIGN, SETTING, AND PARTICIPANTS: We retrieved data on the incidence and mortality of bladder cancer from the GLOBOCAN database, Cancer Incidence in Five Continents, and the WHO mortality database. Data on the rate of tobacco use were retrieved from the WHO Global Health Observatory. Data on GDP per capita was retrieved from the United Nations Human Development Report. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We performed two sets of analyses. The first set of analysis is based on bladder cancer incidence and mortality data in 2018. The gender-specific age-standardised rates (ASRs) of incidence and mortality, and their correlations with the rate of tobacco use and GDP per capita were investigated. A multivariable linear regression analysis was also performed. In the second set of analysis, we examined the 10-yr temporal trends of bladder cancer incidence and mortality by average annual percent change using joinpoint regression analysis. A further exploratory analysis on GDP per capita in countries with decreasing trends of tobacco use was also performed. RESULTS AND LIMITATIONS: Wide variations in bladder cancer incidence and mortality were observed globally. There were positive correlations between the rate of tobacco use and the ASRs of bladder cancer incidence (r=0.20) and mortality (r=0.38) in men, and between the rate of tobacco use and the ASRs of bladder cancer incidence (r=0.67) and mortality (r=0.22) in women. There were positive correlations between GDP per capita, and the ASRs of bladder cancer incidence in men (r=0.48) and women (r=0.44). There was a weak positive correlation between GDP per capita and bladder cancer mortality in men (r=0.19), but no correlation with bladder cancer mortality in women (r=0.06). Upon multivariable linear regression analysis, tobacco use was significantly associated with bladder cancer incidence and mortality in men, and bladder cancer incidence in women. Regarding the 10-yr temporal trends of bladder cancer, Europe has an increasing incidence but decreasing mortality, and Asia has a decreasing incidence but increasing male mortality. Among countries with decreasing trends of tobacco use, the mean GDP per capita was higher in countries with decreasing trends of bladder cancer mortality than in those with increasing trends of bladder cancer mortality. A major limitation of the study is that cancer incidence might be underdetected and under-reported in less developed nations. CONCLUSIONS: There were observable trends of bladder cancer incidence and mortality globally. Tobacco use was significantly associated with both bladder cancer incidence and mortality. A certain level of economic capacity might be needed to further reduce bladder cancer mortality in countries with a decreasing trend of tobacco use. PATIENT SUMMARY: There are different trends of bladder cancer incidence and mortality globally. Smoking is significantly associated with the incidence and mortality of bladder cancer. A higher financial capacity may be needed to further improve the disease outcomes.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Teoh JY, Huang J, Ko WY, et al. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. Eur Urol. 2020. PMID: 32972792. doi:10.1016/j.eururo.2020.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。